CLOVER HEALTH INVESTMENTS, CORP. /DE Payments for Repurchase of Other Equity
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- CLOVER HEALTH INVESTMENTS, CORP. /DE payments for repurchase of other equity for the quarter ending 2025-03-31 was $13.66M, a 306.64% increase year-over-year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE payments for repurchase of other equity for the quarter ending 2024-12-31 was $6.80M, a 722.25% increase year-over-year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE payments for repurchase of other equity for the quarter ending 2024-09-30 was $4.89M, a 145.04% increase year-over-year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE payments for repurchase of other equity for the quarter ending 2024-06-30 was $1.45M.
- CLOVER HEALTH INVESTMENTS, CORP. /DE payments for repurchase of other equity for fiscal 2024 was $16.49M, a 165.13% increase from fiscal 2023.
- CLOVER HEALTH INVESTMENTS, CORP. /DE payments for repurchase of other equity for fiscal 2023 was $6.22M, a 2.23% decline from fiscal 2022.
- CLOVER HEALTH INVESTMENTS, CORP. /DE payments for repurchase of other equity for fiscal 2022 was $6.36M.
| Period end | Payments for Repurchase of Other Equity 3 month | Payments for Repurchase of Other Equity 12 month |
|---|---|---|
| 2025-03-31 | $13.66M 10-Q · filed 2025-05-09 | $26.79M derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-12-31 | $6.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $16.49M 10-K · filed 2025-03-03 |
| 2024-09-30 | $4.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $10.52M derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-06-30 | $1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $7.63M derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-03-31 | $3.36M 10-Q · filed 2025-05-09 | |
| 2023-12-31 | $827.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $6.22M 10-K · filed 2025-03-03 |
| 2023-09-30 | $1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | |
| 2022-12-31 | $6.36M 10-K · filed 2025-03-03 |